Loading organizations...
Loading organizations...
Biotechnology company programming the human immune system.
Immusoft has raised $34.1M across 5 funding rounds.
Immusoft has raised $34.1M in total across 5 funding rounds.
Immusoft has raised $34.1M in total across 5 funding rounds.
Immusoft's investors include Maria Millan, Alexandria Venture Investments, Breakout Ventures, DEFTA Partners, Mesa Verde Venture Partners, RBV Capital, Sean Ainsworth, Founders Fund, Technium Partners, Thiel Foundation.
Immusoft has raised $34.1M across 5 funding rounds. Most recently, it raised $8.0M Grant in January 2023.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 27, 2023 | $8.0M Grant | Maria Millan | |
| Jan 3, 2019 | $20.0M Series B | Alexandria Venture Investments, Breakout Ventures, DEFTA Partners, Mesa Verde Venture Partners, RBV Capital | |
| Jan 5, 2018 | $3.0M Series B | Sean Ainsworth | |
| Nov 11, 2016 | $2.7M Other Equity | Founders Fund, Technium Partners | |
| Apr 21, 2012 | $350K Grant | Thiel Foundation |